eISSN: 1731-2531
ISSN: 1642-5758
Anaesthesiology Intensive Therapy
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2023
vol. 55
 
Share:
Share:
Review article

Comparing general anaesthesia versus sedation for endoscopic submucosal dissection: results from a systematic review and meta-analysis

Choy-May Leung
1
,
Rex Wan-Hin Hui
2

  1. Department of Anaesthesiology, Queen Mary Hospital, Hong Kong
  2. Department of Medicine, The University of Hong Kong, Hong Kong
Anaesthesiol Intensive Ther 2023; 55, 1: 9–17
Online publish date: 2023/03/02
Article file
- Comparing general.pdf  [0.61 MB]
Get citation
 
PlumX metrics:
 

Endoscopic submucosal dissection (ESD) is an ad-vanced endoscopic procedure for treating early-stage gastrointestinal tumours [1]. It enables en-bloc resection of lesions with organ preservation and is associated with better outcomes than other endoscopic resection procedures [2]. ESD requires extensive instrumentation in the gastrointestinal tract, and potential adverse outcomes of gastrointestinal bleeding and perforation have been reported [3, 4]. ESD is generally performed under sedation [5, 6]. However, the use of general anaesthesia (GA) in ESD has also been proposed [7]. GA, when compared with sedation, can minimise inadvertent patient movement [8], which may subsequently improve procedural success rates and reduce complications. We performed a systematic review and meta-analysis to compare GA versus sedation in ESD. The primary objectives of this meta-analysis were to compare the en-bloc resection rates and procedural times when comparing GA against sedation in ESD. We hypothesised that GA would lead to higher en-bloc resection rates without impacting the overall procedural time. The secondary objective of this meta-analysis was to compare the complication rates in GA versus sedation in ESD. We hypothesise that the incidence of intra-procedural hemodynamic instability, gastrointestinal perforation, gastrointestinal bleeding, and aspiration pneumonia would be lower in the GA group than in the sedation group.

METHODS

Protocol

This study was registered in PROSPERO (CRD- 42021275813) and was performed as per the PRISMA guidelines.

Literature search and data extraction

We performed a systematic literature search of EMBASE, MEDLINE and Cochrane Library from inception to 31 August 2021. Search terms (including synonyms or MeSH terms) included a combination of 1) general anaesthesia, 2) sedation, and 3) endoscopic submucosal dissection.

Articles in English comparing GA versus sedation in ESD were included. Papers were not excluded based on year or place of publication. Randomised controlled trials, cohort studies and case-control studies were included. Non-original articles, review papers and conference papers were excluded.

The articles were independently screened by two reviewers (RWHH and CML) for inclusion. Data were subsequently extracted from the included articles independently. Extracted data included patient demographics, indication for ESD, procedural time, rate of en-bloc resection, the incidence of intra- procedural vital instability, the incidence of gastrointestinal perforation, the incidence of gastrointestinal bleeding, and the incidence of post-procedural aspiration pneumonia.

Risk of bias evaluation

The risk of bias was measured by the Cochrane Risk of Bias in Non-randomised Studies of Interventions (ROBINS-I) assessment tool [9], which rated bias in the seven domains of confounding, participant selection, classification of interventions, deviations from intended intervention, missing data, outcome measurement and selective reporting. A final assessment of the overall risk of bias was included. The risk of bias was categorised as low, moderate, high, to critical in each domain.

Level of evidence

The overall evidence level was determined by the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach [10], which assessed parameters including indirectness, potential bias, inconsistency, imprecision and other considerations.

Statistical analysis

Analysis was performed on Review Manager, Version 5.4 (Cochrane Collaboration, Oxford, UK) and MetaXL (Epigear). For articles that reported outcomes in median and range only, mean and standard deviation were calculated through validated methods [11]. Outcomes were compared between patients who received ESD under GA or sedation. The weighted mean difference with 95% CI or relative risk (RR) with 95% CI was calculated for continuous outcomes or dichotomous outcomes, respectively. Subgroup analysis was performed based on the ESD subtype (gastric or oeso-phageal). A random effects model was used for meta-analysis. Qualitative comparison (without statistical analysis) was performed for outcomes that were reported in fewer than three studies.

RESULTS

Study selection

A total of 176 articles were retrieved from the lite-rature search. 169 articles were excluded, and seven articles were selected for analysis. Figure 1 depicts the study inclusion and exclusion process.

FIGURE 1

PRISMA diagram showing study selection

/f/fulltexts/AIT/50200/AIT-55-50200-g001_min.jpg

Characteristics of included studies

Seven articles involving seven independent studies were included in the meta-analysis [1218]. The studies were published between 2013 and 2021. Six studies were retrospective cohort studies [1217], and one study was a prospective cohort study [18]. The studies included a total of 1013 patients (518 receiving GA and 495 receiving sedation). Four studies reported ESD in patients with oesophageal neoplasms [1316], and two studies reported ESD in patients with gastric neoplasms [12, 17]. One study involved 39 patients with oeso-phageal neoplasms and 66 patients with gastric neoplasms [18]. Table 1 summarises the characteristics of included studies.

TABLE 1

Characteristics of selected studies

Study and study typePatient numberMean ageMale (%)Indication for ESDGA regimeSedation regime
GASedationGASedationGASedation
Chang 2021
(retrospective cohort)
949464.8 ± 11.165.0 ± 10.488.3%78.7%Gastric neoplasmsInduction: propofol, remifentanil
Maintenance: propofol, remifentanil
Induction: midazolam
Maintenance: propofol, remifentanil
Kim 2020
(retrospective cohort)
758368.0 ± 8.367.2 ± 9.393.3%98.8%Oesophageal neoplasmsInduction: propofol, remifentanil
Maintenance: remifentanil, sevoflurane
Dexmedetomidine, propofol
Hamada 2019
(retrospective cohort)
1029669.8 ± 7.468.3 ± 7.887.3%86.5%Oesophageal neoplasmsInduction: propofol, sevoflurane
Maintenance: remifentanil, sevoflurane
Midazolam
Song 2018
(retrospective cohort)
829365.3 ± 7.663.7 ± 8.093.9%91.4%Oesophageal neoplasmsInduction: midazolam, propofol
Maintenance: propofol, remifentanil
Midazolam, propofol, remifentanil
Kuwata 2016
(retrospective cohort)
8216NRNRNRNROesophageal neoplasmsInduction: propofol, sevoflurane
Maintenance: remifentanil, sevoflurane
Midazolam
Yurtlu 2016
(retrospective cohort)
375464.4 ± 10.961.4 ± 13.345.9%38.9%Gastric neoplasmsInduction: fentanyl, midazolam
Maintenance: fentanyl, sevoflurane
Induction: fentanyl, midazolam
Maintenance: propofol
Rong 2013
(prospective cohort)
465965.0 ± 12.058.1 ± 11/043.5%49.2%Oesophageal neoplasms (16 GA, 23 sedation); gastric neoplasms (30 GA, 36 sedation)Induction: midazolam, propofol
Maintenance: propofol, fentanyl
Diazepam

[i] ESD – endoscopic submucosal dissection, GA – general anaesthesia, NR – not reported

Primary outcomes

En-bloc resection

The rates of en-bloc resection were reported in six studies [1214, 1618]. The rate of en-bloc resection was 1.04 in GA compared with sedation, although this difference was not statistically significant (RR 1.04; 95% CI: 0.99–1.09; I2 = 71%; P = 0.08) (Figure 2A).

FIGURE 2

Relative risks of en-bloc resection between general anaesthesia and sedation groups in the whole cohort (A) and in oesophageal endoscopic submucosal dissection only (B)

/f/fulltexts/AIT/50200/AIT-55-50200-g002_min.jpg

When stratified by ESD subtype, the en-bloc resection rate was higher in GA than in sedation for oesophageal ESD (RR 1.05; 95% CI: 1.00–1.10; I2 = 65%; P = 0.05) (Figure 2B) [13, 14, 16].

No quantitative analysis was performed in the gastric ESD subgroup due to the inclusion of two studies only. Chang et al. [12] reported comparably high rates of en-bloc resection for both GA and sedation groups (95.7% vs. 97.9%, P = 0.68). Similar results were reported by Yurtlu et al. [17] as well (97.3% vs. 98.1%, P = 0.24). The study with mixed ESD indications did not report on en-bloc resection rates in the subgroups and was excluded from the subgroup analysis [18].

Procedural times

All seven studies reported on ESD procedural times, as defined by the time from initiation to termination of ESD [1218]. The procedural times were comparable in GA and sedation (mean difference 3.47 minutes; 95% CI: –19.42 to 26.35; I2 = 97%; P = 0.77) (Figure 3A).

FIGURE 3

Weighted mean difference of procedural time between general anaesthesia and sedation groups in the whole cohort (A) and in oesophageal endoscopic submucosal dissection only (B)

/f/fulltexts/AIT/50200/AIT-55-50200-g003_min.jpg

When stratified by ESD subtype, procedural times were statistically comparable between GA and sedation in oesophageal ESD (mean difference 11.75 minutes; 95% CI: –9.03 to 32.53; I2 = 85%; P = 0.27) (Figure 3B) [1316].

Only two studies reported procedural times in gastric ESD patients. Chang et al. [12] reported longer procedural times in GA patients than in sedation patients for gastric ESD (103.9 vs 82.4 minutes, P = 0.003). In contrast, Yurtlu et al. [17] reported a numerically shorter but statistically comparable procedural time in GA and in sedation (36.3 vs. 44.4 minutes, P = 0.094). The study with mixed ESD indications did not report procedural times in the subgroups and was excluded from the subgroup analysis [18].

Secondary outcomes

Intra-procedural vital instability

Intra-procedural vital instability was reported in four studies [1315, 18]. As various definitions were used in the different studies, qualitative assessment without quantitative comparison was performed. Rong et al. [18] reported no cases of hypotension or respiratory depression in either the GA or sedation group (definition of hypotension and respiratory depression not provided). Yurtlu et al. [17] reported one case of desaturation (oxygen saturation < 90%) in their GA group versus 10 cases of desaturation in their sedation group. Kim et al. [14] reported no cases of vital instability in GA patients versus two cases of fast atrial fibrillation (heart rate not provided) and one case of desaturation (oxygen saturation < 90%) in their sedation group. Hamada et al. [13] reported no cases of vital instability in GA patients versus seven cases of hypotension (systolic pressure < 90 mm Hg), five cases of bradycardia (heart rate < 50 beats per minute), three cases of bradypnea (respiratory rate < 8 per minute) and two cases of hypoxia (oxygen saturatio n < 90%) in their sedation group.

Gastrointestinal perforation

Six articles reported incidence of gastrointestinal perforation, defined by overt perforations seen on endoscopy or micro-perforations detected through post-procedural X-ray [1217]. When compared with the sedation group, patients under GA had a relative risk of 0.62 to have gastrointestinal perforation, and this difference was borderline significant (RR 0.62; 95% CI: 0.21–1.82; I2 = 52%; P = 0.06) (Figure 4A).

FIGURE 4

Relative risks of gastrointestinal perforation between general anaesthesia and sedation groups in the whole cohort (A) and in oesophageal endoscopic submucosal dissection only (B)

/f/fulltexts/AIT/50200/AIT-55-50200-g004_min.jpg

Five studies reported on incidence of perforation in oesophageal ESD, and the relative risk of perforation was statistically comparable in GA and sedation (RR 0.41; 95% CI: 0.13–1.29; I2 = 23%; P = 0.27) (Figure 4B).

Only two studies reported perforation rates in gastric ESD, and both studies reported statistically comparable perforation rates between GA and sedation groups, respectively (3.3% vs. 5.6% and 12.8% vs. 5.3% respectively; both P > 0.05) [12, 18].

Gastrointestinal bleeding

Six studies reported incidence of post-procedural gastrointestinal bleeding, defined as clinically overt gastrointestinal bleeding requiring further endoscopic therapy [1216, 18]. No significant differences in bleeding risk were noted between GA and sedation (RR 0.75; 95% CI: 0.28–2.01; I2 = 0%; P = 0.48) (Figure 5A).

FIGURE 5

Relative risks of gastrointestinal bleeding between general anaesthesia and sedation groups in the whole cohort (A) and in oesophageal endoscopic submucosal dissection only (B)

/f/fulltexts/AIT/50200/AIT-55-50200-g005_min.jpg

In oesophageal ESD, the relative risk of bleeding was similar between GA and sedation (RR 0.99; 95% CI: 0.21–4.77; I2 = 0%; P = 0.72) (Figure 5B).

For gastric ESD, two studies reported no significant difference in bleeding rates between GA and sedation groups, respectively (3.3% vs. 19.4% and 4.3% vs. 3.2%; both P > 0.05) [12, 18].

Aspiration pneumonia

Four studies reported on the incidence of post-procedural aspiration pneumonia, defined by post-procedural chest X-ray abnormalities [1315, 17]. The risk of aspiration pneumonia was 0.24 in the GA group compared with sedation. However, this difference was not statistically significant (RR 0.24; 95% CI: 0.05–1.08; I2 = 0%; P = 0.75) (Figure 6A).

FIGURE 6

Relative risks of aspiration pneumonia between general anaesthesia and sedation groups in the whole cohort (A) and in oesophageal endoscopic submucosal dissection only (B)

/f/fulltexts/AIT/50200/AIT-55-50200-g006_min.jpg

In oesophageal ESD, aspiration pneumonia rates were numerically lower in GA compared to sedation (RR 0.19; 95% CI: 0.03–1.07; I2 = 0%; P = 0.62) (Figu- re 6B).

For gastric ESD, Yurtlu et al. [17] reported aspiration pneumonia rates of 1.9% in their sedation group versus no cases in their GA group.

Risk of bias

Confounding

All the studies were cohort studies, and the assignment of patients to sedation or GA was dependent on the clinician’s discretion. This led to potential confounding by baseline tumour status and the presence of comorbidities. Three studies had a moderate risk of confounding [12, 14, 16], as the authors attempted to control for important confounders by regression or stratification. Four studies had a high risk of confounding [13, 15, 17, 18], as confounders were not addressed in the analysis.

Participant selection

Six studies had low bias risk in participant selection [1216, 18]. One study had a high bias risk for participant selection, as the study rejected the first 40 patients from the analysis to account for the learning curve of ESD, yet the first 40 patients all received sedation [17].

Classification of intervention

All studies had low bias risk in the classification of intervention [1218].

Deviations from intended interventions

All studies had a low risk of bias for deviation from intended interventions [1218].

Missing data

All studies had a low risk of missing data [1218].

Outcome measurement

All studies had a low risk of bias in outcome measurement, as all outcomes were objective measures [1218].

Selective reporting

The risk of bias in selective reporting was low in three studies [12, 13, 15]. Two studies had a moderate risk of bias, as multiple analyses and stratification of the same outcomes were noted [14, 16]. Two studies presented different outcomes or cut-offs for analysis in their methodology and result sections, leading to high bias risk in selective reporting [17, 18].

Overall risk of bias

The overall risk of bias was moderate in three studies [12, 14, 16] and high in four studies [13, 15, 17, 18]. Table 2 depicts the breakdown of the risk of bias.

TABLE 2

Risk of bias assessment

StudyConfoundingParticipant selectionClassification of interventionsDeviations from intended interventionsMissing
data
Outcome measurementSelective reportingOverall risk
of bias
Chang 2021ModerateLowLowLowLowLowLowModerate
Kim 2020ModerateLowLowLowLowLowModerateModerate
Hamada 2019HighLowLowLowLowLowLowHigh
Song 2018ModerateLowLowLowLowLowModerateModerate
Kuwata 2016HighLowLowLowLowLowLowHigh
Yurtlu 2016HighHighLowLowLowLowHighHigh
Rong 2013HighLowLowLowLowLowHighHigh

Level of evidence

The evidence level was low when rated by the GRADE approach. The risk of bias was a key factor leading to low certainty.

DISCUSSION

Our meta-analysis demonstrated that the en-bloc resection rate in oesophageal ESD was higher in GA when compared with sedation. En-bloc resection is associated with lower rates of tumour recurrence, which is a crucial advantage of ESD over other endoscopic resection methods [19, 20]. As the oesophagus has a thin wall and narrow lumen, a stable working field is required for successful en-bloc resection [16]. GA obviates the risk of undersedation and likely results in less inadvertent patient movement than sedation [8], which can explain its impact on increasing en-bloc resection rates in oesophageal ESD. The impact of GA on en-bloc resection was not observable for gastric ESD, and this may be explained by the larger lumen size of the stomach, which provides greater endoscopic manoeuvrability. As gastric ESD is less technically demanding than oesophageal ESD [21], the benefit of minimising patient movement through GA may be less apparent in gastric procedures.

The procedural times in our meta-analysis had high heterogeneity (I2 = 97%), and no significant difference in procedural time between GA and sedation was noted in the pooled analysis. Previous studies have reported tumour size and anatomical location as the key determinants of ESD procedural times [22, 23], as these factors can affect dissection speed. Other factors, including patient factors, have not been demonstrated to affect ESD procedural times [22, 23]. Future studies should aim to further characterise factors affecting procedural time, as endoscopic procedural time has potential implications for the efficiency of endoscopy suite operation [24]. Of note, the studies included in this review defined procedural time from initiation to completion of ESD but did not report on the time required for patient preparation and anaesthesia. The total patient contact time, including anaesthetic, pre-procedural preparation, and procedural and post-procedural recovery times should be reported in subsequent studies, as these data have important implications for endoscopy suite utility and cost-effectiveness.

Our meta-analysis also demonstrated a trend towards lower gastrointestinal perforation risk in GA when compared with sedation in ESD. As perforation is a rare event, the relatively small number of patients in this meta-analysis may mean the study is underpowered to investigate the association between GA and perforation. Gastrointestinal perforation is one of the most serious complications of ESD [20]. While perforations in ESD may be managed conservatively, cases requiring emergency surgery have been reported [25, 26]. Measures to prevent a perforation in ESD include adequate hands-on training, selection of suitable ESD equipment, and modification of ESD techniques based on tumour location and size [3]. GA may provide a more stable working field for ESD [8], which may, in turn, reduce the risk of gastrointestinal perforation.

Intra-procedural desaturation appeared to occur less frequently in patients undergoing GA than in sedation for ESD, although the heterogenous outcome reporting precluded quantitative comparison. Aspiration is a common adverse event in ESD [27, 28], and an advantage of GA is that endotracheal intubation is performed, and continuous airway protection is maintained throughout the procedure [29]. The lower rates of intra-procedural desaturation in GA patients may be attributable to better intra- procedural airway protection. Furthermore, we also observed a numerically lower rate of post-procedural aspiration pneumonia in GA patients, supporting the potential impact of GA on reducing respiratory complications in ESD.

The incidence of intra-procedural hypotension and arrhythmia was incompletely reported in included studies, limiting our ability to draw meaningful conclusions on the cardiovascular effects of GA in ESD. Nonetheless, effective sedative dosing and patient tolerability to endoscopy can vary substantially among patients, leading to difficulty maintaining a stable and adequate sedation level [29, 30]. Repeated dosing of sedatives during ESD may result in cardiovascular instability [29], and GA may be a more straightforward and safe option for maintaining intra-procedural cardiovascular stability.

Several limitations should be considered. First, the included studies all had relatively small sample sizes. The majority of included studies (six out of seven) were also retrospective studies. This meta-analysis may hence be underpowered to detect rare complications such as gastrointestinal bleeding or perforation. Multi-centre prospective studies or randomised trials should be considered for investigating the association between GA and ESD adverse events. Second, all studies had a moderate to high risk of bias, especially in confounding, which led to low evidence levels. The choice between GA versus sedation was based on clinician discretion in all the included studies, and potential confounding by baseline tumour status and patient comorbidities was possible. Indeed, two articles reported that GA patients had a larger total tumour size and circumferential tumour size when compared with the sedation groups in their respective studies [13, 16]. This suggested that clinicians may be more likely to perform GA in patients with anticipated difficult ESD. Given that more difficult cases were selected for GA, the direction of bias would likely favour the sedation group, and efficacy or safety outcomes would be biased against GA. Nonetheless, GA was associated with higher en-bloc resection rates in oesopha-geal procedures and trended towards lower rates of perforation, desaturation and post-procedural aspiration pneumonia despite potential bias. The results from this meta-analysis appear promising, and the efficacy and safety of GA in ESD warrant further investigation.

Another limitation of this meta-analysis is the limited number of gastric ESD studies [12, 17, 18], which limited subgroup analyses. Furthermore, no evidence of GA in colorectal ESD was identifiable on the systematic literature review. With the promising data on GA in upper gastrointestinal ESD, the use of GA in colorectal ESD should be explored as well.

CONCLUSIONS

The en-bloc resection rates in oesophageal ESD may be higher when using GA when compared with sedation. GA also demonstrated a trend towards lower rates of gastrointestinal perforation, intra-procedural desaturation and post-procedural aspiration pneumonia. Nonetheless, the risk of bias was moderate to high, and the level of evidence was low. High-quality, large-scale trials are warranted before the regular implementation of GA in ESD.

Acknowledgements

  1. Assistance with the article: none.

  2. Financial support and sponsorship: none.

  3. Conflicts of interest: none.

  4. Presentation: Preliminary data from this paper were presented as a poster in Euroanaesthesia 2021 (e-conference, 17/12/2021-19/12/2021).

References

1 

Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-854. doi: 10.1055/s-0034-1392882.

2 

Lian J, Chen S, Zhang Y, Qiu F. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc 2012; 76: 763-770. doi: 10.1016/j.gie.2012.06.014.

3 

Kim SG, Hwang JH. How to decrease the risk of perforation in endoscopic submucosal dissection (ESD). Techniques in Gastrointestinal Endoscopy 2019; 21: 99-103. doi: 10.1016/j.tgie.2019.05.001.

4 

Kataoka Y, Tsuji Y, Sakaguchi Y, et al. Bleeding after endoscopic submucosal dissection: risk factors and preventive methods. World J Gastroenterol 2016; 22: 5927-5935. doi: 10.3748/wjg.v22.i26.5927.

5 

Takeuchi Y, Yamaguchi D, Yamaguchi N, et al. Propofol sedation in the endoscopy room versus operation room during endoscopic submucosal dissection for gastric tumors: a propensity score-matching analysis. Digestion 2020; 101: 450-457. doi: 10.1159/000500874.

6 

Ashikari K, Nonaka T, Higurashi T, et al. Efficacy of sedation with dexmedetomidine plus propofol during esophageal endoscopic submucosal dissection. J Gastroenterol Hepatol 2021; 36: 1920-1926. doi: 10.1111/jgh.15417.

7 

Mori H, Kobara H, Muramatsu A, et al. Comparison of postoperative complications after endoscopic submucosal dissection: differences of insufflations and anesthesias. Diagn Ther Endosc 2011; 2011: 709237. doi: 10.1155/2011/709237.

8 

Sidhu R, Turnbull D, Newton M, et al. Deep sedation and anaesthesia in complex gastrointestinal endoscopy: a joint position statement endorsed by the British Society of Gastroenterology (BSG), Joint Advisory Group (JAG) and Royal College of Anaesthetists (RCoA). Frontline Gastroenterol 2019; 10: 141-147. doi: 10.1136/flgastro-2018-101145.

9 

Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919. doi: 10.1136/bmj.i4919.

10 

Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011; 64: 380-382. doi: 10.1016/j.jclinepi.2010.09.011.

11 

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; 14: 135. doi: 10.1186/1471-2288-14-135.

12 

Chang JI, Kim TJ, Hwang NY, et al. Clinical outcomes and adverse events of gastric endoscopic submucosal dissection of the mid to upper stomach under general anesthesia and monitored anesthetic care. Clin Endosc 2022; 55: 77-85. doi: 10.5946/ce.2021.002.

13 

Hamada K, Kawano K, Yamauchi A, et al. Efficacy of endoscopic submucosal dissection of esophageal neoplasms under general anesthesia. Clin Endosc 2019; 52: 252-257. doi: 10.5946/ce.2018.151.

14 

Kim SH, Choi YS, Lee SK, Oh H, Choi SH. Comparison of general anesthesia and conscious sedation in procedure-related complications during esophageal endoscopic submucosal dissection. Surg Endosc 2020; 34: 3560-3566. doi: 10.1007/s00464-020-07663-9.

15 

Kuwata N, Gotoda T, Suzuki S, Mukai S, Itoi T, Moriyasu F. Reasonable decision of anesthesia methods in patients who underwent endoscopic submucosal dissection for superficial esophageal carcinoma: a retrospective analysis in a single Japanese institution. Turk J Gastroenterol 2016; 27: 91-96. doi: 10.5152/tjg.2015.150186.

16 

Song BG, Min YW, Cha RR, et al. Endoscopic submucosal dissection under general anesthesia for superficial esophageal squamous cell carcinoma is associated with better clinical outcomes. BMC Gastroenterol 2018; 18: 80. doi: 10.1186/s12876-018-0813-z.

17 

Yurtlu DA, Aslan F, Ayvat P, et al. Propofol-based sedation versus general anesthesia for endoscopic submucosal dissection. Medicine (Baltimore) 2016; 95: e3680. doi: 10.1097/MD.0000000000003680.

18 

Rong QH, Zhao GL, Xie JP, Wang LX. Feasibility and safety of endoscopic submucosal dissection of esophageal or gastric carcinomas under general anesthesia. Med Princ Pract 2013; 22: 280-284. doi: 10.1159/000344002.

19 

Facciorusso A, Antonino M, Di Maso M, Muscatiello N. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc 2014; 6: 555-563. doi: 10.4253/wjge.v6.i11.555.

20 

Guo HM, Zhang XQ, Chen M, Huang SL, Zou XP. Endoscopic submucosal dissection vs endoscopic mucosal resection for superficial esophageal cancer. World J Gastroenterol 2014; 20: 5540-5547. doi: 10.3748/wjg.v20.i18.5540.

21 

Saito Y, Abe S, Inoue H, Tajiri H. How to perform a high-quality endoscopic submucosal dissection. Gastroenterology 2021; 161: 405-410. doi: 10.1053/j.gastro.2021.05.051.

22 

Wen J, Lu ZS, Liu CH, Bian XQ, Huang J. Predictive factors of endoscopic submucosal dissection procedure time for early esophageal cancer. Chin Med J (Engl) 2021; 134: 1373-1375. doi: 10.1097/CM9.0000000000001355.

23 

Konuma H, Matsumoto K, Ueyama H, et al. Procedure time for gastric endoscopic submucosal dissection according to location, considering both mucosal circumferential incision and submucosal dissection. Gastroenterol Res Pract 2016; 2016: 9183793. doi: 10.1155/2016/9183793.

24 

Yang D, Summerlee R, Suarez AL, et al. Evaluation of interventional endoscopy unit efficiency metrics at a tertiary academic medical center. Endosc Int Open 2016; 4: E143-E148. doi: 10.1055/s-0041-108082.

25 

Sato H, Inoue H, Ikeda H, et al. Clinical experience of esophageal perforation occurring with endoscopic submucosal dissection. Dis Esophagus 2014; 27: 617-622. doi: 10.1111/dote.12125.

26 

Toyokawa T, Inaba T, Omote S, et al. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastroenterol Hepatol 2012; 27: 907-912. doi: 10.1111/j.1440-1746.2011.07039.x.

27 

Park CH, Kim H, Kang YA, et al. Risk factors and prognosis of pulmonary complications after endoscopic submucosal dissection for gastric neoplasia. Dig Dis Sci 2013; 58: 540-546. doi: 10.1007/s10620-012-2376-0.

28 

Watari J, Tomita T, Toyoshima F, et al. The incidence of “silent” free air and aspiration pneumonia detected by CT after gastric endoscopic submucosal dissection. Gastrointest Endosc 2012; 76: 1116-1123. doi: 10.1016/j.gie.2012.07.043.

29 

Yamashita K, Shiwaku H, Ohmiya T, et al. Efficacy and safety of endoscopic submucosal dissection under general anesthesia. World J Gastrointest Endosc 2016; 8: 466-471. doi: 10.4253/wjge.v8.i13.466.

30 

Hui RW, Leung CM. Patient-controlled sedation versus clinician-administered sedation for endoscopic retrograde cholangiopancreatography: a systematic review. Anesth Analg 2022; 134: 765-772. doi: 10.1213/ANE.0000000000005766.

This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.